Abstract
We can use Artificial Neural Networks (ANNs) and graph Topological Indices (TIs) to seek structure-property relationship. Balabans’ J index is one of the classic TIs for chemo-informatics studies. We used here Markov chains to generalize the J index and apply it to bioinformatics, systems biology, and social sciences. We seek new ANN models to show the discrimination power of the new indices at node level in three proof-of-concept experiments. First, we calculated more than 1,000,000 values of the new Balaban-Markov centralities Jk(i) and other indices for all nodes in >100 complex networks. In the three experiments, we found new MIANN models with >80% of Specificity (Sp) and Sensitivity (Sn) in train and validation series for Metabolic Reactions of Networks (MRNs) for 42 organisms (bacteria, yeast, nematode and plants), 73 Biological Interaction Webs or Networks (BINs), and 43 sub-networks of U.S. Supreme court citations in different decades from 1791 to 2005. This work may open a new route for the application of TIs to unravel hidden structure-property relationships in complex bio-molecular, ecological, and social networks.
Keywords: Artificial neural networks, complex networks, metabolomics, ecosystems, U.S. supreme court, legal and social networks, Markov chains.
Current Bioinformatics
Title:MIANN Models of Networks of Biochemical Reactions, Ecosystems, and U.S. Supreme Court with Balaban-Markov Indices
Volume: 10 Issue: 5
Author(s): Aliuska Duardo-Sanchez, Humberto Gonzalez-Diaz and Alejandro Pazos
Affiliation:
Keywords: Artificial neural networks, complex networks, metabolomics, ecosystems, U.S. supreme court, legal and social networks, Markov chains.
Abstract: We can use Artificial Neural Networks (ANNs) and graph Topological Indices (TIs) to seek structure-property relationship. Balabans’ J index is one of the classic TIs for chemo-informatics studies. We used here Markov chains to generalize the J index and apply it to bioinformatics, systems biology, and social sciences. We seek new ANN models to show the discrimination power of the new indices at node level in three proof-of-concept experiments. First, we calculated more than 1,000,000 values of the new Balaban-Markov centralities Jk(i) and other indices for all nodes in >100 complex networks. In the three experiments, we found new MIANN models with >80% of Specificity (Sp) and Sensitivity (Sn) in train and validation series for Metabolic Reactions of Networks (MRNs) for 42 organisms (bacteria, yeast, nematode and plants), 73 Biological Interaction Webs or Networks (BINs), and 43 sub-networks of U.S. Supreme court citations in different decades from 1791 to 2005. This work may open a new route for the application of TIs to unravel hidden structure-property relationships in complex bio-molecular, ecological, and social networks.
Export Options
About this article
Cite this article as:
Duardo-Sanchez Aliuska, Gonzalez-Diaz Humberto and Pazos Alejandro, MIANN Models of Networks of Biochemical Reactions, Ecosystems, and U.S. Supreme Court with Balaban-Markov Indices, Current Bioinformatics 2015; 10 (5) . https://dx.doi.org/10.2174/1574893610666151008012752
DOI https://dx.doi.org/10.2174/1574893610666151008012752 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Circulating MicroRNAs as Biomarkers for Inflammatory Diseases
MicroRNA Molecules and Metabolites from Natural Products as Inhibitors of Biofilm in Candida spp. pathogens
Current Topics in Medicinal Chemistry Molecular Mechanisms of Biological Activity of Oleanolic Acid - A Source of Inspiration for A New Drugs Design
Mini-Reviews in Organic Chemistry Aminobisphosphonates as New Weapons for γ δ T Cell-Based Immunotherapy of Cancer
Current Medicinal Chemistry Advancement Towards Tin-based Anticancer Chemotherapeutics: Structural Modification and Computer Modeling Approach to Drug-Enzyme Interactions
Current Topics in Medicinal Chemistry Editorial from Guest Editor (Thematic Issue: Current Approaches and Models to Develop and Evaluate New Vaccines and Drugs Against Tuberculosis)
Current Respiratory Medicine Reviews Anti-Inflammatory Therapy in Uveitis
Recent Patents on Inflammation & Allergy Drug Discovery Th17 and Treg Cells, Two New Lymphocyte Subpopulations with a Key Role in the Immune Response Against Infection
Infectious Disorders - Drug Targets Ureas: Applications in Drug Design
Current Medicinal Chemistry Structure-Based Drug Design to Overcome Drug Resistance: Challenges and Opportunities
Current Pharmaceutical Design Recent Development and Application of Virtual Screening in Drug Discovery: An Overview
Current Pharmaceutical Design Resources and Tools for Investigating Biomolecular Networks in Mammals
Current Pharmaceutical Design 1,2,5-Thiadiazole Scaffold: A Review on Recent Progress in Biological Activities
Combinatorial Chemistry & High Throughput Screening Bronchoscopy in Children for Research with Questionable Indications: An Overview of Russian Patents and Publications
Recent Patents on Drug Delivery & Formulation Ribonucleotide Reductase: A Critical Enzyme for Cancer Chemotherapy and Antiviral Agents
Recent Patents on Anti-Cancer Drug Discovery Microwave: An Important and Efficient Tool for the Synthesis of Biological Potent Organic Compounds
Current Medicinal Chemistry Unified Multi-target Approach for the Rational in silico Design of Anti-bladder Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Receptor Binding Ligands to Image Infection
Current Pharmaceutical Design Redox Proteins as Targets for Drugs Development Against Pathogens
Current Pharmaceutical Design Synthesis, Characterization of (E)-N'-(substituted-benzylidene)isonicotinohydrazide Derivatives as Potent Antitubercular Agents
Letters in Drug Design & Discovery